Article Details
Retrieved on: 2021-07-02 14:46:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The trial success of CRISPR gene-editing technology has broad applications to treating other diseases, Intellia Therapeutics CEO John Leonard said.
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here